Menstrual induction and cervical priming prior to evacuation

  • N. H. Lauersen
  • Z. R. Graves
Part of the Advances in Reproductive Health Care book series (ARHE, volume 4)


As the number of reported induced abortions in the United States approaches one million, it becomes more important to develop effective abortion techniques, free of both immediate complications and sequelae. Early interruption techniques are particularly attractive since, as a general rule, the number of procedure-related complications increases as gestation lengthens. The demand for early interruption has been enhanced both by an increasingly informed patient population and the availability of highly sensitive pregnancy tests which are 95% accurate within days after conception.


Early Pregnancy Fertility Regulation Suction Curettage Posterior Fornix Vaginal Suppository 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ballard, C. A., Forte, K. and Lauerson, N. H. (1978). Plasma Prostaglandin concentration and abortifacient effectiveness of a single insertion of a 3-mg 115(S)methyl-prostaglandin F methyl ester vaginal suppository. Contraception, 17, 383–392PubMedCrossRefGoogle Scholar
  2. Bygdeman, M., Green, K., Bergstrom, S., Bundy, G. and Kimball, F. A. (1979). A new Prostaglandin E2 analog for pregnancy termination. Lancet, 1, 1136PubMedCrossRefGoogle Scholar
  3. Bygdeman, M., Martin, J. N., Leader, A., Lundstrom, V., Ramadan, M., Eneroth, P. and Green, K. (1978). Early pregnancy interruption by 15(S) 15 methyl Prostaglandin F methyl ester. Obstet. Gynecol., 48, 221–224Google Scholar
  4. Csapo, A. I. and Pulkkinen, M. O. (1979). The mechanism of Prostaglandin action on the pregnant human uterus. Prostaglandins, 17, 283–299PubMedCrossRefGoogle Scholar
  5. Csapo, A. I., Herczeg, J., Pulkkinen, M., Kaihola, H. I., Zoltan, I., Csillag, M. and Mocsary, P. (1976). Termination of pregnancy with double Prostaglandin impact. Am. J. Obstet. Gynecol., 135, 1116Google Scholar
  6. Dingfelder, J. R., Brenner, W. E., Hendricks, C. H. and Staurovsky, L. G. (1975). Reduction of cervical resistance by Prostaglandin suppositories prior to dilatation for induced abortion. Am. J. Obstet. Gynecol., 122, 25–30PubMedGoogle Scholar
  7. Eaton, C. J., Cohn, G. and Bollinger, C. C. (1972). Laminaria tent as a cervical dilator prior to aspiration-type therapeutic abortion. Obstet. Gynecol., 39, 535–537PubMedGoogle Scholar
  8. Ganguli, A. C., Green, K. and Bygdeman, M. (1977). Preoperative dilatation of the cervix by single vaginal administration of 15-methyl-PGF-methyl ester. Prostaglandins, 14, 779–784PubMedCrossRefGoogle Scholar
  9. Grimes, D. A., Schulz, K. F., Cates, W. Jr., and Tyler, C. W. Jr. (1977). Methods of midtrimester abortion: Which is safest? Int. J. Gynaecol. Obstet., 15, 184–186PubMedGoogle Scholar
  10. Grimes, D. A., Schulz, K. F., Cates, W. Jr. and Tyler, C. W. Jr. (1977). Mid-trimester abortion by dilatation and evacuation -A safe and practical alternative. N. Engl. J. Med., 296, 1141–1145PubMedCrossRefGoogle Scholar
  11. Karim, S. M. (ed.) (1975). In: Prostaglandins and Reproduction, pp. 77–148Google Scholar
  12. Lauersen, N. H. (1979). Investigation of Prostaglandins for abortion. Acta. Obstet. Gynecol. Scand., pp. 1–36Google Scholar
  13. Lauersen, N. H. and Wilson, K. H. (1976). Luteolytic and abortifacient effects of serial intramuscular injections of 15(S)-15-methyl-prostaglandin F in early pregnancy. Am. J. Obstet. Gynecol., 124, 425–429PubMedGoogle Scholar
  14. Lauersen, N. H. and Wilson, K. H. (1977). The effect of a 10-cm2, 0.5% 15-ME-PGF methyl ester intravaginal silastic device on abortion and plasma Prostaglandin concentration. Prostaglandins, 13, 755–762PubMedCrossRefGoogle Scholar
  15. Lauersen, N. H. and Wilson, K. H. (1980). Early pregnancy interruption with two 15-ME-PGF suppositories. Contraception, 21, 273–282PubMedCrossRefGoogle Scholar
  16. Lauersen, N. H., Kurkulos, M., Graves, Z. R. and Leeds, L. (1982). A new IUD insertion technique utilizing cervical priming with Prostaglandin. Contraception, 26, 59–63PubMedCrossRefGoogle Scholar
  17. Lauersen, N. H., Seidman, S. and Wilson, K. H. (1979). Cervical priming prior to first-trimester suction abortion with a single 15-methyl-prostaglandin-F vaginal suppository. Am. J. Obstet. Gynecol., 135, 1116–1118PubMedGoogle Scholar
  18. Mandelin, M. (1978). Termination of early pregnancy by a single-dose 3.0 mg 15-methyl PGF methyl ester vaginal suppository. Prostaglandins, 16, 143–152PubMedCrossRefGoogle Scholar
  19. Scher, J., Jing, D. Y. and Kerenyi, T. D. (1980). Post-conceptional induction of menses with a single vaginal suppository of 15(S)-15-methyl-prostaglandin F methyl ester. Prostaglandins, 3, 469–485CrossRefGoogle Scholar
  20. Wentz, A. C. and Jones, G. S. (1973). Intravenous Prostaglandin F for induction of menses. Fertil. Steril., 24, 569–577PubMedGoogle Scholar

Copyright information

© MTP Press Limited 1984

Authors and Affiliations

  • N. H. Lauersen
  • Z. R. Graves

There are no affiliations available

Personalised recommendations